Milestone Scientific (MLSS) Shares Outstanding (Diluted Average) (2010 - 2026)
Milestone Scientific's (MLSS) quarterly Shares Outstanding (Diluted Average) came in at $85.0 million in Q1 2026, up 3.89% year-on-year from $81.9 million in Q1 2025, and up 3.63% quarter-over-quarter from $82.1 million in Q4 2025.
Milestone Scientific (MLSS) Shares Outstanding (Diluted Average) (2010 - 2026) Analysis & Trends
Milestone Scientific has disclosed Shares Outstanding (Diluted Average) across 17 years of filings, most recently posting $85.0 million for Q1 2026.
- Shares Outstanding (Diluted Average) for Q1 2026 came in at $85.0 million, up 3.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $85.0 million (up 3.89% YoY), and the FY2025 annual result was $82.1 million, up 2.85% from the prior year.
- Shares Outstanding (Diluted Average) came in at $85.0 million for Q1 2026 at Milestone Scientific, up from $82.1 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $85.0 million in Q1 2026 to a low of $69.0 million in Q1 2022.
- The 5-year median for Shares Outstanding (Diluted Average) is $80.2 million (2024), against an average of $77.7 million.
- Across the five-year window, Shares Outstanding (Diluted Average) climbed 2.01% in 2022 and advanced 11.17% in 2024, its largest moves.
- Milestone Scientific's Shares Outstanding (Diluted Average) stood at $71.0 million in 2022, then grew by 1.91% to $72.3 million in 2023, then grew by 10.31% to $79.8 million in 2024, then advanced by 2.85% to $82.1 million in 2025, then climbed by 3.63% to $85.0 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $85.0 million (Q1 2026), $82.1 million (Q4 2025), and $82.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 359.80 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 824.84 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.72 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 175.50 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.61 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Milestone Scientific | 28.92 Mn | 27.73 Mn | 1.56 Mn | 85.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85.04 Mn |
| Dec 31, 2025 | 82.06 Mn |
| Sep 30, 2025 | 82.32 Mn |
| Mar 31, 2025 | 81.85 Mn |
| Dec 31, 2024 | 79.79 Mn |
| Sep 30, 2024 | 80.17 Mn |
| Jun 30, 2024 | 80.41 Mn |
| Jun 30, 2023 | 72.33 Mn |
| Sep 30, 2022 | 70.98 Mn |
| Jun 30, 2022 | 70.59 Mn |
| Mar 31, 2022 | 69.01 Mn |
| Dec 31, 2021 | 68.83 Mn |
| Sep 30, 2021 | 69.57 Mn |
| Jun 30, 2021 | 68.29 Mn |
| Mar 31, 2021 | 66.58 Mn |
| Dec 31, 2020 | 63.06 Mn |
| Sep 30, 2020 | 65.82 Mn |
| Jun 30, 2020 | 51.73 Mn |
| Mar 31, 2020 | 49.73 Mn |
| Dec 31, 2019 | 45.74 Mn |